{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:58:55Z","timestamp":1773673135996,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.imlet.2025.107127","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:10:05Z","timestamp":1767139805000},"page":"107127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and application of a multi-epitope ACE2 antigen for detection of autoantibodies in post-COVID-19 diagnosed type 1 diabetes"],"prefix":"10.1016","volume":"279","author":[{"given":"Maryam","family":"Marzban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayebali","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fattah","family":"Sotoodehnejadnematalahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.imlet.2025.107127_bib0001","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.mpmed.2022.07.002","article-title":"What is type 1 diabetes?","volume":"50","author":"Quinn","year":"2022","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.imlet.2025.107127_bib0002","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3892\/br.2024.1770","article-title":"Viruses as a potential environmental trigger of type 1 diabetes mellitus (Review)","volume":"20","author":"Alves Abrantes","year":"2024","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.imlet.2025.107127_bib0003","doi-asserted-by":"crossref","unstructured":"Lemos, J. R. N., K. Hirani and M. von Herrath (2024). \"Immunological and virological triggers of type 1 diabetes: insights and implications\". Volume 14, 2023.","DOI":"10.3389\/fimmu.2023.1326711"},{"key":"10.1016\/j.imlet.2025.107127_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110034","article-title":"COVID-19 induced Diabetes: a novel presentation","volume":"191","author":"Chandrashekhar Joshi","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.imlet.2025.107127_bib0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/jama.2024.11174","article-title":"Progression from presymptomatic to clinical Type 1 diabetes after COVID-19 infection","volume":"332","author":"Friedl","year":"2024","journal-title":"JAMa"},{"key":"10.1016\/j.imlet.2025.107127_bib0006","doi-asserted-by":"crossref","first-page":"q1557","DOI":"10.1136\/bmj.q1557","article-title":"Covid-19: progression to clinical type 1 diabetes accelerated after infection, study suggests","volume":"386","author":"Wise","year":"2024","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.imlet.2025.107127_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266809","article-title":"The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a nationwide cohort from the US using the Cerner Real-World Data","volume":"17","author":"Qeadan","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.imlet.2025.107127_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.596898","article-title":"SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in human pancreatic \u03b2-cells and in the human pancreas microvasculature","volume":"11","author":"Fignani","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.imlet.2025.107127_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115734","article-title":"Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments","volume":"168","author":"Antar","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.imlet.2025.107127_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41392-023-01580-8","article-title":"The role of cell death in SARS-CoV-2 infection","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.imlet.2025.107127_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13733","article-title":"ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes","volume":"233","author":"Memon","year":"2021","journal-title":"Acta Physiol. (Oxf)"},{"key":"10.1016\/j.imlet.2025.107127_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102683","article-title":"Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19","volume":"122","author":"Rodriguez-Perez","year":"2021","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.imlet.2025.107127_bib0013","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s11010-022-04396-2","article-title":"An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning \u03b2-cell survival and cardiovascular conditions in diabetic patients","volume":"477","author":"Srivastava","year":"2022","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.imlet.2025.107127_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109183","article-title":"Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection","volume":"112","author":"Vahabi","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.imlet.2025.107127_bib0015","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1007\/s10072-021-05506-6","article-title":"Anti-GAD associated post-infectious cerebellitis after COVID-19 infection","volume":"42","author":"Emekli","year":"2021","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.imlet.2025.107127_bib0016","doi-asserted-by":"crossref","first-page":"e6597","DOI":"10.1002\/ccr3.6597","article-title":"Autoimmune meningoencephalitis associated with anti-glutamic acid decarboxylase antibody following COVID-19 infection: a case report","volume":"10","author":"Salari","year":"2022","journal-title":"Clin. Case Rep."},{"issue":"9","key":"10.1016\/j.imlet.2025.107127_bib0017","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.clinthera.2023.06.026","article-title":"Long COVID-19 and Insulin Autoimmune Syndrome: A Case Report","volume":"45","author":"Corona-Meraz","year":"2023","journal-title":"Clin. Ther."},{"issue":"11","key":"10.1016\/j.imlet.2025.107127_bib0018","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-1551","article-title":"New-Onset Type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K","volume":"43","author":"Unsworth","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.imlet.2025.107127_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231210403","article-title":"COVID-19 induced type 1 diabetes: a systematic review of case reports and series","volume":"51","author":"Stathi","year":"2023","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.imlet.2025.107127_bib0020","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2492211","article-title":"New onset of type 1 and type 2 diabetes post-COVID-19 infection: a systematic review","volume":"14","author":"El-Naas","year":"2025","journal-title":"Emerg. Microbes. Infect."},{"key":"10.1016\/j.imlet.2025.107127_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ph17111498","article-title":"Design, development and immunogenicity study of a multi-epitope vaccine prototype against SARS-CoV-2","volume":"17","author":"Atanasova","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.imlet.2025.107127_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.110804","article-title":"Multi-epitopevaccines, from design to expression; an in silico approach","volume":"85","author":"Mortazavi","year":"2024","journal-title":"Hum. Immunol."},{"issue":"31","key":"10.1016\/j.imlet.2025.107127_bib0023","doi-asserted-by":"crossref","first-page":"993","DOI":"10.15585\/mmwr.mm7131a3","article-title":"Post-COVID-19 symptoms and conditions among children and adolescents - United States, March 1, 2020-January 31, 2022","volume":"71","author":"Kompaniyets","year":"2022","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.imlet.2025.107127_bib0024","article-title":"Incident new onset diabetes after COVID-19 infection: results from a national multicenter cohort","volume":"8","author":"Zisis","year":"2023","journal-title":"J. Diabetes Treat."},{"issue":"4","key":"10.1016\/j.imlet.2025.107127_bib0025","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402694R","article-title":"Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection","volume":"39","author":"Galipeau","year":"2025","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.imlet.2025.107127_bib0026","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s43856-024-00477-z","article-title":"Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity","volume":"4","author":"Geanes","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.imlet.2025.107127_bib0027","article-title":"Immunological and virological triggers of type 1 diabetes: insights and implications","volume":"14","author":"Lemos","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107127_bib0028","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-003167","article-title":"Causal associations between type 1 diabetes and COVID-19 infection and prognosis: a two-sample Mendelian randomization study","volume":"11","author":"Ma","year":"2023","journal-title":"BMJ Open. Diabetes Res. Care"},{"issue":"5","key":"10.1016\/j.imlet.2025.107127_bib0029","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","article-title":"COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection","volume":"40","author":"Beyerstedt","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.imlet.2025.107127_bib0030","doi-asserted-by":"crossref","unstructured":"Bradley, T., E. Geanes, R. McLennan and C. LeMaster (2023). \"Autoantibodies against Angiotensin-converting enzyme 2 and immune molecules are associated with COVID-19 disease severity\". Res Sq.","DOI":"10.21203\/rs.3.rs-3304083\/v1"},{"issue":"2 Suppl 2","key":"10.1016\/j.imlet.2025.107127_bib0031","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2025.107127_bib0032","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158362","article-title":"IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function","volume":"7","author":"Casciola-Rosen","year":"2022","journal-title":"JCI Insight"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:43:50Z","timestamp":1773668630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"alternative-id":["S0165247825001609"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107127","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and application of a multi-epitope ACE2 antigen for detection of autoantibodies in post-COVID-19 diagnosed type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107127"}}